2 completed, 1 recruiting, 1 withdrawn. 4 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 2, Recruiting 1, Withdrawn 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow AgelessRx: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effectiveness of Alternative Therapies in Maintaining Weight Loss Achieved by GLP-1 Medications Post-Cessation Metformin, Rapamycin, Naltrexone - Longevity, GLP-1 | Phase 2 / Phase 3 | Recruiting | AgelessRx | 150 | 2024-12-17 | 2025-07-30 |
| Pilot Study Into the Use of Metformin and LDN for Patients With COVID-19 Metformin, Naltrexone - Covid19 | Phase 2 | Withdrawn | AgelessRx | 2021-02-01 | 2022-10-04 | |
| Pilot Study Into LDN and NAD+ for Treatment of Patients With Post-COVID-19 Syndrome Naltrexone, NAD+ - Covid19, Long COVID-19 | Phase 2 | Completed | AgelessRx | 36 | 2021-01-28 | 2023-01-25 |
| Participatory Evaluation (of) Aging (With) Rapamycin (for) Longevity Study Rapamycin, Placebo - Aging | Phase 2 | Completed | AgelessRx | 129 | 2020-01-01 | 2024-01-24 |
COVID-19 (2) · Post-Acute COVID-19 Syndrome (1)
Naltrexone (3) · Metformin (2) · Sirolimus (2) · Ascorbic Acid (1) · NAD (1)
United States (4)
Sajad Zalzala, MD (3) · James Watson, MD (1) · Stefanie Morgan, PhD (1)